Vitamin B ,
 


 
.    ,   
 !к#$ %& '()к* +,- .


  '. /01
234 56789 ,- . 8 () +6+':  2 +67;
 <=& >?@6  ;AB

B) , 2 х
DEB=F . B 
 #,-GHI .   * к*'0 '() яK L@M *

N>)GHI . я5O APQB H3'R @SB P@T N>)GHI . 567BUVW X 
 

56@ B=& яDEB ;AB
YB  . <+Z[,- --Vitamin B ,
 - S'P %\ *>)] B


 #,-к*'=' !. L'( B)(^S'PB P%T
Y *  /A^B G>'
AS'PB

+6_ P@T `@6 'P P@T G>' @SB H34(

+Za B) >'+6=F'bI ...

 : <'() 2 b ` c
B)d кIe 'X 5f =g -'hid j
 /

kYca  h *kMcl . >) `cl 30 >'. L@  H34(

<'@ +6 7 kYF'P !() . "#$ nc "

/'. " `'>кo@p * , h'01+=q * , ]LAZr +=q * , `@6B" "/
@  s%() 2 >кL '

erкS>M )'. " `BAZ *" +tSM 

%u ;
': c 
'b&Hcl .кLh v>M wxy * кo zI@  

ш|c ;AL9 к* <' ] G.'я}4  * , ] >?~+=c€  * /A>c  H "

B)d(vitamins) , хя AB  * (minarals), >?~#$  * (trace eliments)" /

 кca  b&kcl . `BAZ * 

  ;
':0 ‚ /A>c  '%\4 '=F . B 

xH| N>)к*R c  2 /ƒ ',к #$ A:)Q ... / `'+Z,- H ! (deficiency) ]

H
() к* =SN9 , >SX„EB hicl ( , 'P %\I
%& * #… '(к#$ AZ яS8 /Aш  B=F .

]'@ /A^BG>  † '=F H

>  :(A'01 ..

B
T яK%--

*
 B1 (thiamine),

*
 B2 (S5‡ ˆ‰d
-riboflavin),

*
 B3 (9`e != niacinamide),

*
 B4 (/0\ƒ-adenine),

*
 B5 (#'%u%&Š-pantothenic acid),

*
 B6 (pyridoxine, pyridoxal, != pyridoxamine, ),

*
 B7 (biotin),

*
 B8 "'(adenosine),

*
 B9 (‹$ IŠ  d'-folic acid),


 Œ10 (PABA)# / 5Ž'яXŠ 9`e ),

*
  12 (

_ cobalamins;
 >hd D'‘T 2 kYca' cyanocobalamin),

*some rare B-vitamins

*
 B11: ‹$ IŠ  d' ’к“ ”к c•+' <=F pteryl-hepta-glutamic acid-]'@ '=F

hicl ( /'ш'. @clH@ `BAZ к* /A>cDEB –() folates ”к кB)—cl .
 S !=

cк' (factor)˜ / к™0 h *kMcl

*
 B13: orotic 9`e, ”к+Z[,-
  
'b&Hcl .. <+Z[,- %\IeB=F ”к


() / .

*
 B14: šd š S˜ =r кB)—501B=F. h‰cl cell proliferant, cкM ›œB@,  *к hicl (

/'ш', S9 antitumor pterin ‹e‰‘. 0.33ppm A(ž `BA Ÿ%6 (@clH@ cкM ' 2) B)'01

HRclb&9501B=F ƒ S'@ k~

' %u €S': 5, !(). @clH@ /@ =rR кS':501'=F .

/@B) к™0 † xanthopterin !( h‰—“cl .

*
 B15: pangamic 9`e,

*
 B16: dimethylglycine (DMG),

*
 B17: nitrilosides, amygdalin != Laetrile. † +=q *
@M  *,   к *, ¡T,

tubers, S9 Y

2 SM':A:)Q. hi(ž +S `a' 2
  / +67#(к* * <=F

/'|кS'bcl .ve¢M w9 Y * !к#$ A,' (ca#… '( !() . 

BTš P@T S9 Hca 2

+b&9B H=F'bcl.

 B18:

 B19:

 B20: carnitine,


 B21:

 B22: @c:? / 2HR B)'01 H3IN9()cl ’к“ ”к Ÿ A>)MAZ  + * <@c

 * 2 h‰—“cl. / ”к Ÿ ' =r h‰—“cl
 B12b.


 +£ * :

h'01+=q ;c¤ L9 2 +£ +0& 'я}4¥
  + b&>M )'=F.  c' 2 2he‰M кI

d  ()ž5c,', '0\(,,/ >, ƒc>' A' ~a * >'Œ
kMX.

'(S' :,', b&@p * UV


` *

B
B)d † L'=F ;AL9 к* /A>c' A:)Q:

* (ž @p S9 ;AL9 8§ hicl ( ,

* 
A'@DEB :, x§f S9 к', kqX cr›¨':0 ,

* H
YF _к S9 0© A
A>q z'~ hi':) GA0 ,

* cкM ›œB@ YF':0 >9+0& cL cкM кa %u >, eiª hicl ( S9 eiª 01
я +6s‘

b&90 ,

*b ` #6a'@кDEB c•# 2 ”к /XB Gd 

BTš Ab&Q /Av @S«>M )'=F -

/Rк ;AL9 2 G-'я}4  *  +b&kM X .

/ B
B)d ƒ кS8HR, S9 ш|c' /'@ H

hM b\'=F 'X.  /(B+Z


/A>c  !B+Z,- Ÿ@6' 2
>S¬':5,%X .

B
B)d к™0 (of 2§B) , /YFк c

­ @ 2+' ’к“ ~a * Dcl  +,0

+£ +,%X . †
9  2 B4
 /A>c  . †
 B) /0\ƒ(adenine)

/'cl
B
 2+'

/Rк h‰cl
 2+' H

_) *--- @SB'@ B-
B)d !к#$ A,' zI@' кIS

',A:)Q. B
B)d 2+  A B кI8 ()[Sa ` * L'=F .5ª 2 :?h':5=FB
;

ƒ 2 кS8 ]
B)d :

ck9к B?B
@(deficiency)

 ®'b& +=€ *
  A B кI8 H
_) *

_) A' Y

*,

HRclшB A' B?3

5ŽS 5Ž,S кI
1 _9` S'я *, B)AZr S'я * ,
'(S':'
# *, `'> , b&+,

,-d, 9 Ÿc *.

# *, ,-d,  !9  ,
+t@,  Ÿ d2
2 }¯5‡ ˆ‰d
 Ÿ@6h', , к*
+ '
к™c *

# *,  !9 ,

`'> , ,-° 2 cкM ›œB@, =&r ,

6 hi4S0T k… B, b&+ *, Y

*, 01 ', ' 2

Pк*“,- яK7 9 *, 2# *

9к™c *.

 !9 , `'> , cкM ›œB@, /7kc ,

B9-‹$ IŠ ‹$ IŠ
,-d, # *, z ` *, %\ d cкM кa * Bf
 d   d 
Y
*, к* к™c * #$ A 
 c +=€ 2

®':(). h‰  2
>9` G
 12 5±fS9  * =g кc cкM ›œB@
5 DE
>'v²da  b&e ш|

/'=FkM X

  яK7 z ` *

(e6˜) , s * ,

k“SOŠ 9к™c *, 5'U

e >“}r
 d  ()'+ *, I³d Aš, ]

+',d ´
>) *,

+PQc+9 *.

%яK9к™c *,

B5--  !9 , Ÿ@6
#'µ¶FBŠ
#'µ¶FBŠ h', , †˜f , ,-° 2 UVW ', 
 d 
 d  k… B, `'> , P ,

()'+ *, HRclшB , %&3

++Z[ =FB)>) *,
к', ·+Z[ *, 0©
5£ S'я *, 9к™c *,
5£ ', ' 2 %&0 *,
vitamin B7  !9 ,
/ >
Ÿ@6h', 
B

+tS@'(Toxicity):

/@
'@ B
B)d Ÿ@6' 2 кL ' @+[к*'0 %¸ S':5,%X /X%& ] B
B)d hi(ž

s%() 2 N>)GA,' кcDEB +6H * @[7M b&9A:)Q.
 к*“A s%() 2

b `  #§ N>)к*Bd X%& H7 kqX 5f кcDEB +6H * к *  %X .

 B1 thiamine k=ca    ¹ !().  =r N>)GA,' 2 ]'@ '=F  S¬Š

+tS@' кh':)B). ec != к', 2 /YFк s%() º9` >?=F '() * A B

/» `T˜ nŠ Ab&Q ] HR=Fк * X.

 B2 S5‡ ¼d
 ¹ !(). +S@ `BA S9 я'@p /_

9 * Yc' S5‡ ¼d


>'5'_' +67к™ +6H B) `@6 k~

' .S5‡ ¼d
 NA6DEB кh'b& S9 UV '7 5›¨c«@'

B+Z[,- >['(@к Tя яK@p (free radicals) @[7M (e‰rb½¾ *) @9`cAZB
µ6

/_
9 * 2 %&IB=F .

 B3 9`e- '() * != 5 Acq кDEB c' B)'01 35 ¿d L  * / x 3000

nicotinamide S9 1500 GŠ 9`e mg / x N>)к*Bd X%&
c', H'@p *,

d GÀ
P * S9  !9
+tS@' ’к“ ~a * >'5'_' кIS 'X. <@c +6H * Ÿ

>S+,к(glucose intolerence- reversible) +6@

~DEB +6H * кIS 'X. /(B',

GŠ 9`e c•+' 2 к™0 :c' cl+Z, @c:) +ZÁS§˜, @ ·h[ %u к™01 '§'=F, <=F ”к

()c(, я (S':', != %&Iк# 5S'Â >': , кIe , cL5c,' / h *kMcl -

vasodilatory +6H *, S9 к# `'@c« @ cкM +6H^' hiSS' /+Z[,+Z[,- @ ·h[ кIS':)B)

. H34(
+Za * 2000 MG s%() 2 /YFк Ih kqX >'(à d 2 _  h‰d Š /®Ao=F€

/aPHR9,' G>  >?P'b& > 9' 2 9`e † ei4 »iĊf * к * я8>M )'=F .

 B5 -#'%u%&Š 9`e - %u %\IeB
+tS@' ¹ !() .

 B6 pyridoxine 100 '() *, '() * != 5 Acq кDEB c' B)'01 mg / x 1000
к'. к*“A mg / x N>)к*Bd X%& +cYg9 яKyB B?
+7(peripheral sensory

neuropathy)кI8 k“c  '=F; <@c +6H * clxAZ  !(): :c>'5'_ 9` * я'PB

žAZ d 2 2 B6 2+  A RB clxAZ  !() .

 B7 biotin - %\IeB
+tS@' ¹ !() .

 B9 ‹$ IŠ  d' 1 mg / x HR>)]R +ÆÇB ' 12 ' 2+' B) кh':к*'0 b&9,'(masks

the B12 deficiency) A B vшr@ B Bf' к* =SN>)M'=F , hi|9˜ ƒ9` кI8

/Aш  B=F .

 B12 cobalamin - /YFк   N>)GA,' A B Bf  ¹ !() .   -A' (()žcld

AkM9 È * X.